The primary aim of this study was to explore the safety profile of biologic treatments in Behçet's disease (BD), based on their mechanism of action; the secondary aim was to study any potential variation in terms of retention rate according to each single drug.

Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study / Cantarini, Luca; Talarico, Rosaria; Generali, Elena; Emmi, Giacomo; Lopalco, Giuseppe; Costa, Luisa; Silvestri, Elena; Caso, Francesco; Franceschini, Rossella; Cimaz, Rolando; Iannone, Florenzo; Galeazzi, Mauro; Selmi, Carlo. - In: INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES. - ISSN 1756-185X. - STAMPA. - 20:(2017), pp. 103-108. [10.1111/1756-185X.12732]

Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study

EMMI, GIACOMO;SILVESTRI, ELENA;CIMAZ, ROLANDO;
2017

Abstract

The primary aim of this study was to explore the safety profile of biologic treatments in Behçet's disease (BD), based on their mechanism of action; the secondary aim was to study any potential variation in terms of retention rate according to each single drug.
2017
20
103
108
Goal 3: Good health and well-being for people
Cantarini, Luca; Talarico, Rosaria; Generali, Elena; Emmi, Giacomo; Lopalco, Giuseppe; Costa, Luisa; Silvestri, Elena; Caso, Francesco; Franceschini, Rossella; Cimaz, Rolando; Iannone, Florenzo; Galeazzi, Mauro; Selmi, Carlo
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1056723
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 15
social impact